Clinical Trials on Hormone Receptor Positive in South Africa
Total 2390 results
-
National Cancer Institute (NCI)NRG OncologyRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast Carcinoma | Metastatic Hormone Receptor-Positive Breast CarcinomaUnited States, Puerto Rico
-
National Cancer Institute (NCI)NCIC Clinical Trials Group; Cancer and Leukemia Group B; North Central Cancer... and other collaboratorsActive, not recruitingHormone Receptor Positive | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States, Canada, Australia, Puerto Rico, New Zealand, Ireland, Peru, United Kingdom
-
HIV Vaccine Trials NetworkNational Institute of Allergy and Infectious Diseases (NIAID); Biofabri, S.LRecruitingTuberculosis | HIV I InfectionSouth Africa
-
Médecins Sans Frontières, FranceHarvard Medical School (HMS and HSDM); Institute of Tropical Medicine, Belgium and other collaboratorsCompletedTuberculosis, Multidrug-Resistant | Infection, Bacterial | Pulmonary TuberculosesPakistan, Georgia, India, Kazakhstan, Lesotho, Peru, South Africa
-
The Aurum Institute NPCJohns Hopkins UniversityRecruitingTuberculosis | HIV Seropositivity | Household ContactSouth Africa, India, Indonesia, Mozambique
-
Medecins Sans Frontieres, NetherlandsLondon School of Hygiene and Tropical Medicine; University of Liverpool; Ministry... and other collaboratorsCompletedMulti-drug Resistant Tuberculosis | Pulmonary Tuberculoses | Extensively Drug-Resistant TuberculosisBelarus, South Africa, Uzbekistan
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingInflammatory Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor NegativeUnited States
-
IUATLD, IncMedical Research Council; Institute of Tropical Medicine, Belgium; Liverpool... and other collaboratorsCompletedMDR-TBEthiopia, Georgia, India, Moldova, Republic of, Mongolia, South Africa, Uganda
-
ANRS, Emerging Infectious DiseasesEuropean and Developing Countries Clinical Trials Partnership (EDCTP); European...RecruitingTuberculous MeningitisCôte D'Ivoire, Madagascar, South Africa, Uganda
-
Prof Gerhard WalzlLondon School of Hygiene and Tropical Medicine; Makerere University; Leiden University... and other collaboratorsCompletedPulmonary TuberculosisUnited Kingdom, Uganda, Ethiopia, Gambia, Germany, Namibia, Netherlands, South Africa
-
Yaounde Central HospitalUniversity of Exeter; University of Yaounde 1; MRC/UVRI & LSHTM Uganda Research...RecruitingType 1 Diabetes | Diabetes, AutoimmuneTanzania, Cameroon, South Africa, Uganda
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)TerminatedHIV Infection | TuberculosisPeru, Brazil, South Africa, Haiti, Kenya
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingStage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | HER2-Positive Breast Carcinoma | Hormone Receptor-Positive Breast CarcinomaUnited States, Puerto Rico
-
Foundation for Innovative New Diagnostics, SwitzerlandSwiss Tropical & Public Health Institute; University of Cape Town; The HIV Netherlands... and other collaboratorsCompletedDiagnosis of Tuberculosis in People Living With HIVMalawi, South Africa, Tanzania, Thailand, Uganda, Vietnam, Zambia
-
NovaBay Pharmaceuticals, Inc.CompletedImpetigoUnited States, South Africa
-
Ferrer Internacional S.A.CompletedEfficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With ImpetigoImpetigoGermany, South Africa
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedBreast Carcinoma | Estrogen Receptor Negative | Progesterone Receptor NegativeUnited States, Guam
-
Hasanuddin UniversityCompletedSemi Seated Position | Side Lying PositionIndonesia
-
University of California, San FranciscoJohns Hopkins UniversityNot yet recruitingTuberculosis, Pulmonary | Tuberculosis, Multidrug-Resistant | Tuberculosis, MDRPeru, Vietnam, Moldova, Republic of, Mongolia, Pakistan, Philippines, South Africa
-
Merck Sharp & Dohme LLCCompletedPneumococcal InfectionsUnited States, France, Peru, South Africa, Thailand
-
Bill & Melinda Gates Medical Research InstituteWellcome TrustCompletedHuman Immunodeficiency VirusSouth Africa
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Croatia, Poland, Romania, South Africa, Turkey
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID); National Institute...CompletedHIV Infections | TuberculosisPeru, South Africa, Botswana, Brazil, India, Malawi, Zimbabwe
-
ExelixisActive, not recruitingA Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (STELLAR-001)Renal Cell Carcinoma | Colorectal Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor Positive Breast Carcinoma | Neoplasm MalignantUnited States, Australia, Belgium, Czechia, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | TuberculosisHaiti, South Africa, Thailand, Tanzania, Botswana, Zimbabwe, India, Uganda
-
Janssen Infectious Diseases BVBACompletedTuberculosisSouth Africa, Peru, Latvia, Philippines, Russian Federation, Thailand, Brazil, India
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Astellas Pharma US, Inc.Active, not recruitingSalivary CancerUnited States
-
McGill UniversityCanadian Institutes of Health Research (CIHR)CompletedLatent Tuberculosis InfectionCanada, Australia, Benin, Brazil, Ghana, Guinea, Indonesia
-
Serum Institute of India Pvt. Ltd.Vakzine Projekt Management GmbHActive, not recruitingMycobacterium Tuberculosis InfectionGabon, Kenya, South Africa, Tanzania, Uganda
-
AmgenRecruitingSolid TumorsCanada, Korea, Republic of, Australia, Netherlands, United States, Israel, Austria, Spain, United Kingdom, France, Belgium, Japan, Czechia, Hungary, Poland, Brazil, Argentina, Denmark, Greece, Mexico, Switzerland, Romania, Italy, Finland and more
-
Centers for Disease Control and PreventionBritish Medical Research CouncilRecruitingLatent TuberculosisAustralia, United States, Canada, South Africa
-
Abbott ProductsQuintiles, Inc.CompletedType 2 DiabetesBulgaria, Poland, South Africa
-
Partners in HealthHarvard Medical School (HMS and HSDM); Epicentre; Interactive Research and Development and other collaboratorsCompletedTuberculosis, Multidrug-ResistantGeorgia, Armenia, Bangladesh, Belarus, Ethiopia, Indonesia, Kazakhstan, Kenya, Kyrgyzstan, Lesotho, Myanmar, Pakistan, Peru, South Africa
-
SanofiCompletedChronic Heart FailureCanada, United States, United Kingdom
-
Eli Lilly and CompanyCompletedType 2 DiabetesIndia, Mexico, New Zealand, South Africa
-
Janssen Research & Development, LLCCompletedProstatic NeoplasmsUnited States, Canada
-
Molecular Templates, Inc.TerminatedHER2-positive Solid CancersUnited States, Australia, New Zealand
-
Centers for Disease Control and PreventionUS Department of Veterans AffairsCompletedTuberculosisUganda, United States, Canada, South Africa
-
University Medical Center GroningenUnknownTuberculosis, Multidrug-ResistantSweden, United Kingdom, Australia, Belarus, Brazil, Greece, Italy, Latvia, Mexico, Netherlands, Portugal, South Africa, Tanzania
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, South Africa
-
Global Alliance for TB Drug DevelopmentCompletedTuberculosis | Tuberculosis, Pulmonary | Tuberculosis, Multidrug-Resistant | Extensively Drug-Resistant Tuberculosis | Tuberculosis, MDR | XDR-TB | Pre-XDR-TBSouth Africa, Russian Federation, Georgia, Moldova, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Turkey, Egypt, Philippines, United Arab Emirates, Bangladesh, Colombia, Singapore, South Africa
-
Hoffmann-La RocheCompletedRenal Cell Carcinoma | Chronic Myelogenous Leukemia | Malignant MelanomaCanada, India, Bulgaria, Russian Federation, Spain, South Africa, Slovakia
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, South Africa, Russian Federation, Former Serbia and Montenegro, North Macedonia
-
Novartis PharmaceuticalsTerminatedPhilidelphia Positive Chronic Myeloid LeukaemiaAustralia
-
SanofiCompletedType 2 Diabetes MellitusSouth Africa, United States, Mexico, United Kingdom
-
Organon and CoCompletedHypogonadotropic HypogonadismBrazil, Denmark, Italy, Mexico, Russian Federation, South Africa
-
Centers for Disease Control and PreventionCompletedLatent Tuberculosis InfectionUnited States, China, South Africa, Spain
-
SanofiCompletedType 2 Diabetes MellitusArgentina, Colombia, Egypt, Hong Kong, India, Indonesia, Lebanon, Malaysia, Peru, Philippines, Saudi Arabia, South Africa, Thailand, Turkey
-
SanofiGenzyme, a Sanofi CompanyCompletedProstate Cancer | Metastatic | Hormone RefractoryBrazil, South Africa, Sweden, Germany, Hungary